Workflow
Cibus(CBUS)
icon
搜索文档
Cibus(CBUS) - 2020 Q1 - Quarterly Report
2020-05-07 09:38
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020; or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38161 Calyxt, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1967997 (State or other ...
Cibus(CBUS) - 2019 Q4 - Earnings Call Transcript
2020-03-06 03:27
Calyxt, Inc. (CLXT) Q4 2019 Earnings Conference Call March 5, 2020 8:30 AM ET Company Participants Chris Tyson - MD, MZ North America, IR Jim Blome - CEO Bill Koschak - CFO Dan Voytas - Chief Science Officer Conference Call Participants John Baumgartner - Wells Fargo Ben Klieve - National Securities Adam Samuelson - Goldman Sachs Ken Zaslow - Bank of Montreal Adam Bubes - Jefferies Robert Leboyer - Ladenburg Thalmann Steve Byrne - Bank of America Merrill Lynch Operator Good morning, ladies and gentlemen. Th ...
Cibus(CBUS) - 2019 Q4 - Earnings Call Presentation
2020-03-06 03:12
calyxt INVESTOR PRESENTATION (NASDAQ: CLXT) March 5, 2020 FORWARD LOOKING STATEMENTS This communication contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other compar ...
Cibus(CBUS) - 2019 Q4 - Annual Report
2020-03-05 10:45
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019; or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38161 Calyxt, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1967997 (State or other juri ...
Calyxt (CLXT) Investor Presentation - Slideshow
2019-12-16 04:03
业绩总结 - Calyxt的市场资本为1.783亿美元,股价为5.40美元[4] - 2019年第三季度收入为300万美元,2019年迄今收入为360万美元,预计2019年收入在700万至800万美元之间[4] - 截至2019年6月30日,公司已发行股份总数为32,866,100股[38] - 公司在2019年第三季度报告中创下了记录的财务业绩[38] 用户数据 - Calyxt的种植者保留率为70%,较2019年的54%有所提高[24] - 2019年,Calyxt的种植面积目标为10万英亩,已在2019年合同种植了75000英亩[23] - 2020年,Calyxt的种植面积为76325英亩,较2019年增加了约109%[24] 新产品和新技术研发 - Calyxt正在开发近10种创新新产品,预计在未来两年内实现超过25个阶段的进展[3] - Calyxt的高油酸大豆油产品于2019年3月推出,具有心脏健康的特性[16] - HO大豆油的当前价格预期比商品油高出40%或更多[27] 市场扩张和合作 - 公司与Agtegra和Landus的合作伙伴关系将显著扩大供应链,以满足日益增长的需求[36] - 公司在南达科他州、明尼苏达州、爱荷华州和内布拉斯加州新增最多5个粮仓[26] - 公司在2020年计划租赁10-15辆油罐车和20-30辆漏斗车,以满足预期增长[26] 未来展望 - 公司HO大豆业务的收入预期为700万至800万美元,目标毛利率为10%[27] - 2018年种植的18,000英亩大豆推动了收入增长,目标是种植超过200,000英亩[27] - 全球植物育种和基因组编辑市场预计将从2018年的76亿美元增长到2023年的146亿美元,年复合增长率为14.7%[8] 其他新策略 - 公司计划通过直接销售食品成分和动物营养产品、合作安排以及特征的外部许可来实现多元化收入来源[36]
Cibus(CBUS) - 2019 Q3 - Earnings Call Transcript
2019-11-11 09:37
Calyxt, Inc. (CLXT) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Chris Tyson - Managing Director, MZ North America, Investor Relations Jim Blome - Chief Executive Officer Bill Koschak - Chief Financial Officer Travis Frey - Chief Technology Officer Manoj Sahoo - Chief Business Development, Supply Chain Officer Keith Blanks - Senior Vice President, Sales and Marketing Conference Call Participants Ken Zaslow - Bank of Montreal John Baumgartner - Wells Fargo Laurence Alexan ...
Cibus(CBUS) - 2019 Q3 - Quarterly Report
2019-11-07 07:03
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019; or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38161 Calyxt, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1967997 (State or o ...
Calyxt (CLXT) Presents At Wells Fargo Securities 2019 Consumer Conference & Beauty Forum - Slideshow
2019-09-28 03:05
Making the food you love a healthier choice™ | --- | --- | --- | --- | --- | |------------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | Wells Fargo Consumer Conference S E P T E M B E R 2 6 , 2 0 1 9 | | | | | | | | | | | FORWARD LOOKING STATEMENTS | --- | --- | |-------|-------------------------------------------------------------------------------------------------------------------------------------| | | | | | This communication contains ...
Cibus(CBUS) - 2019 Q2 - Earnings Call Transcript
2019-08-09 20:26
Calyxt, Inc. (CLXT) Q2 2019 Earnings Conference Call August 7, 2019 8:30 AM ET Company Participants Simon Harnest - VP, Corporate Strategy & Finance Jim Blome - CEO Bill Koschak - CFO Conference Call Participants Adam Samuelson - Goldman Sachs Ken Zaslow - BMO Capital Markets John Baumgartner - Wells Fargo Securities Jon Hickman - Ladenburg Thalmann Ben Klieve - National Securities Operator Greetings, and welcome to Calyxt Q2 earnings conference call. [Operator instructions] As a reminder, this conference i ...
Cibus(CBUS) - 2019 Q2 - Quarterly Report
2019-08-07 10:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019; or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38161 Calyxt, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1967997 (State or other ...